Cascadian Therapeutics (FRA:3O61) Other Operating Expense : €0.00 Mil (TTM As of Dec. 2017)

View and export this data going back to . Start your Free Trial

What is Cascadian Therapeutics Other Operating Expense?

Cascadian Therapeutics's Other Operating Expense for the three months ended in Dec. 2017 was €0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2017 was €0.00 Mil.

Cascadian Therapeutics's quarterly Other Operating Expense declined from Jun. 2017 (€0.00 Mil) to Sep. 2017 (€-0.00 Mil) but then increased from Sep. 2017 (€-0.00 Mil) to Dec. 2017 (€0.00 Mil).

Cascadian Therapeutics's annual Other Operating Expense increased from Dec. 2015 (€-0.00 Mil) to Dec. 2016 (€18.71 Mil) but then declined from Dec. 2016 (€18.71 Mil) to Dec. 2017 (€0.00 Mil).

Cascadian Therapeutics Other Operating Expense Historical Data

The historical data trend for Cascadian Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cascadian Therapeutics Other Operating Expense Chart

Cascadian Therapeutics Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Other Operating Expense

Get a 7-Day Free Trial

18.71

Cascadian Therapeutics Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Cascadian Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Cascadian Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Cascadian Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cascadian Therapeutics (FRA:3O61) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cascadian Therapeutics Inc (FRA:3O61) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cascadianrx.com

Cascadian Therapeutics Inc is a clinical-stage biopharmaceutical company focusing in developing innovative therapeutic product candidates for the treatment of cancer. Its objective is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. The company's clinical-stage product candidate includes ONT-380, an orally active and selective small molecule HER2 inhibitor. In addition, it is also engaged in developing preclinical product candidates in oncology using its Checkpoint kinase 1 kinase inhibitor and protocell technology. All the business activity of the firm is functioned through the region of United States.

Cascadian Therapeutics (FRA:3O61) Headlines

No Headlines